Dr. Galsky on Updated CheckMate 274 Data With Adjuvant Nivolumab in Urothelial Carcinoma

Press/Media

Period	15 May 2022

Media coverage

Title	Dr. Galsky on Updated CheckMate 274 Data With Adjuvant Nivolumab in Urothelial Carcinoma
Media name/outlet	OncLive
Country/Territory	United States
Date	15/05/22
URL	https://www.onclive.com/view/dr-galsky-on-updated-checkmate-274-data-with-adjuvant-nivolumab-in-urothelial-carcinoma
Persons	Matthew Galsky